✦ LIBER ✦

Experimental study on inhibition of neuronal toxical effect of Levodopa by Ginkgo Biloba Extract on Parkinson disease in rats

✍ Scribed by Cao Fei; Sun Shenggang; Tong E-tang

Publisher: Springer-Verlag
Year: 2003
Tongue: Chinese
Weight: 324 KB
Volume: 23
Category: Article
ISSN: 0510-9752
DOI: 10.1007/bf02859941

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Experimental study on effect of folium g

Experimental study on effect of folium ginkgo biloba in treating pulmonary interstitial fibrosis in rats

✍ CHEN Jian; HE Bing; LIU Xinmin; WANG Haibin; ZHANG Wei; ZHANG Ying 📂 Article 📅 2000 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 79 KB

In vitro and in vivo effects of an extra

In vitro and in vivo effects of an extract of Ginkgo biloba (EGb 761), ginkgolide B, and bilobalide on apoptosis in primary cultures of rat hippocampal neurons

✍ Jean R. Rapin; Mohamed Zaibi; Katy Drieu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

Primary cultures of rat hippocampal neurons were prepared and exposed to increasing concentrations of a peroxyl radical-generator, 2,2′-azobis 2 amidinopropane (AAPH). Addition of AAPH (20 or 50 mM) to the medium caused a decrease in cell viability and an increase in the number of apoptotic cells. V

Effects of repeated treatments with an e

Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) and bilobalide on glucose uptake and glycogen synthesis in rat erythrocytes: An ex vivo study

✍ Jean R. Rapin; Philippe Provost; Francis V. DeFeudis; Katy Drieu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

The metabolic action of an extract of Ginkgo biloba (EGb 761) has been examined in an ex vivo study of rat erythrocytes. Oral administration of EGb 761 (100 mg/kg/day) for 5 days to Wistar rats caused an increase in the in vitro uptake of glucose by erythrocytes, especially in high-glucose (13.32 mM

Effects of CB1 cannabinoid receptor modu

Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease

✍ Gregorio Segovia; Francisco Mora; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract The present study was designed to determine the potential of CB1 cannabinoid receptor modulating compounds in the treatment of L‐3,4‐dihydroxyphenylalanine (L‐dopa)–induced dyskinesia in Parkinson's disease. In the reserpine‐treated rat model of parkinsonism, administration of a high do